|
2011 Conference Publication Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial DysfunctionCorbier M, Bennett N, Whitbourne L, Roy S, Vesey DA and Gobe G (2011). Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial Dysfunction. World Congress of Nephrology, Vancouver BC, Canada, April 8-12. |
|
2010 Conference Publication Essential metals and cadmium toxicity in the kidneyVesey, David (2010). Essential metals and cadmium toxicity in the kidney. Thailand Reverse Brain Drain Project International Conference on Cadmium in Food and Human Health, Phitsanulok, Thailand, 15-17 January 2010. Phitsanulok, Thailand: Naresuan University. |
|
2010 Conference Publication A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial CellsVesey David A., Suen, Jacky Yung, Johnson, David W. and Fairlie, David (2010). A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells. Kidney Week, American society of Nephrology, Denver Colorado USA, November 16 - 21. Journal of the American Society of Nephrology: |
|
2010 Conference Publication Protease-activated receptor-2 and renal carcinogenesisVesey, D., Rajandram, R., Blakeney, J., Suen, J., Johnson, D., Fairlie, D. and Gobe, G. (2010). Protease-activated receptor-2 and renal carcinogenesis. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth Convention and Exhibition Centre, Perth, Western Australia, 12-15 September 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x |
|
2009 Conference Publication Functional significance of TRAF1 knockdown in renal cell carcinoma anti-cancer treatmentGobe, Glenda C., Rajandram, Retnagowri, Vesey, David A., Wang, Zhiqiang, Bennett, Nigel and Johnson, David W. (2009). Functional significance of TRAF1 knockdown in renal cell carcinoma anti-cancer treatment. American Society of Nephrology Renal Week: 42nd Annual Meeting & Scientific Exposition, San Diego, CA, U.S.A., 27 October - 1 November, 2009. Washington , D.C., U.S.A.: American Society of Nephrology. |
|
2008 Conference Publication Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responsesGobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology. |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney diseaseBennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. HOBOKEN: Australian and New Zealand Society of Nephrology (ANZSN). doi: 10.1111/j.1440-1797.2008.001013.x |
|
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2007 Conference Publication The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapyLi, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. World Congress of Nephrology, Rio De Janeiro, Brazil, 21-25 April , 2007. International Society of Nephrology (ISN). |
|
2007 Conference Publication The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapyLi, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia: |
|
2007 Conference Publication Erythropoietin: Novel applications beyond anaemia treatmentVesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007. |
|
2006 Conference Publication Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathwaysRajandram, R ., Pat, B., Li, J., Percy, C. J., Vesey, D., Johnson, D. W. and Gobe, G. C. (2006). Resistance to cancer treatments in renal cell carcinomas: Discovering novel apoptotic pathways. Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Melbourne, Australia, 14-18 August 2006. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2006.00656.x |
|
2006 Conference Publication Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stressYamada, M., Vesey, D., Johnson, D. W. and Gobe, G. (2006). Protective effect of Angelica sinensis on renal vascular endothelial cell damage induced by oxidative stress. ANZSN 2006: 42nd Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14-19 August 2006. Carlton, Vic., Australia: Blackwell Science. doi: 10.1111/j.1440-1797.2006.00656.x |
|
2006 Conference Publication PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cellsLi, J., Vesey, D. and Gobe, G. (2006). PKC regulation of the cyclin dependent kinase (cdk) inhibitor p21 in normal kidney versus kidney cancer cells. Australia and New Zealand Society of Nephrology and Renal Society of Australasia Annual Scientific Conference, Melbourne, Australia, 14–19 August 2006. |
|
2006 Conference Publication PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responsesGobe, G. C., Johnson, D. W., Kruger, W., Poronnik, P. and Vesey, D. A. (2006). PAR-2 Is expressed by human proximal tubule cells and mediates pro-inflammatory and proliferative responses. Renal Week 2006: American Society of Nephrology Annual Meeting, San Diego, California, U.S., 14 - 19 November, 2006. American Society of Nephrology. |
|
2006 Conference Publication PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cellsLi, Jun, Vesey, David and Gobe, Glenda (2006). PKC regulation of the cyclin dependent kinase inhibitor p21 in normal kidney versus kidney cancer cells. American Society of Nephrology Renal Research Week, San Diego, USA, 2006. ASN. |
|
2005 Conference Publication Cell death in the renal vascular endothelium: an analysis of cytoprotection by erythropoietinYamada, M., Pat, B., Vesey, D., Johnson, D. and Gobe, G. (2005). Cell death in the renal vascular endothelium: an analysis of cytoprotection by erythropoietin. 5th Annual Health and Medical Research Conference of Queensland, Brisbane, Queensland, 3-4 November 2005. |
|
2005 Conference Publication Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietinGobe, G., Yamada, M., Pat, B., Vesey, D. and Johnson, D. W. (2005). Cell death in the renal vascular endothelium: An analysis of cytoprotection by erythropoietin. 41th [sic] Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Wellington, New Zealand, 3-7 September 2005. Carlton, Vic.: Blackwell Science. doi: 10.1111/j.1440-1797.2005.00461.x |
